Marek's disease virus-transformed chicken T-cell lines respond to lymphokines

Mark Kaplan, Anju Dhar, Thomas R. Brown, Roy S. Sundick

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Current assays for chicken interleukin-2 (IL-2) utilize mitogen-activated lymphocytes. However, very high inter-assay variability and sporadic high background proliferation limit their usefulness. In view of the above, several Marek's disease virus (MDV)-transformed T-cell lines (which grow well in a serum-supplemented medium) were tested for a response to chicken IL-2 when grown in serum-free media. Five of six lines examined showed a dose-dependent proliferative response to chicken T-cell conditioned media. One line, MDCC-CU14, was chosen for further studies. In addition to the tumor cells' dose-dependent responses to semi-purified chicken IL-2, they expressed T-cell activation antigens on the cell surface. Furthermore, the level of surface expression was enhanced on cells provided IL-2. Co-incubation of the tumor cells with monoclonal antibody INN-CH-16 (specific for an antigen on the surface of activated T-cells) and IL-2 resulted in a modulation of lymphokine-induced proliferation. Together, these data suggest that signalling mechanisms in MDV T-cell tumors are intact and that these lines can be used as an assay for chicken T-cell lymphokines. Furthermore, they provide an interesting model for the study of avian and mammalian T-cell transformation. Implications for the study of Marek's disease are also discussed.

Original languageEnglish (US)
Pages (from-to)63-79
Number of pages17
JournalVeterinary Immunology and Immunopathology
Volume34
Issue number1-2
DOIs
StatePublished - 1992
Externally publishedYes

Fingerprint

lymphokines
Marek Disease
Mardivirus
Lymphokines
Chickens
T-lymphocytes
Interleukin-2
cell lines
interleukin-2
chickens
Viruses
T-Lymphocytes
Cell Line
CD27 Antigens
assays
Neoplasms
Transformed Cell Line
antigens
Serum-Free Culture Media
Surface Antigens

ASJC Scopus subject areas

  • Animal Science and Zoology
  • Immunology
  • veterinary(all)

Cite this

Marek's disease virus-transformed chicken T-cell lines respond to lymphokines. / Kaplan, Mark; Dhar, Anju; Brown, Thomas R.; Sundick, Roy S.

In: Veterinary Immunology and Immunopathology, Vol. 34, No. 1-2, 1992, p. 63-79.

Research output: Contribution to journalArticle

Kaplan, Mark ; Dhar, Anju ; Brown, Thomas R. ; Sundick, Roy S. / Marek's disease virus-transformed chicken T-cell lines respond to lymphokines. In: Veterinary Immunology and Immunopathology. 1992 ; Vol. 34, No. 1-2. pp. 63-79.
@article{0ded696efad442cba475789922ae0a9d,
title = "Marek's disease virus-transformed chicken T-cell lines respond to lymphokines",
abstract = "Current assays for chicken interleukin-2 (IL-2) utilize mitogen-activated lymphocytes. However, very high inter-assay variability and sporadic high background proliferation limit their usefulness. In view of the above, several Marek's disease virus (MDV)-transformed T-cell lines (which grow well in a serum-supplemented medium) were tested for a response to chicken IL-2 when grown in serum-free media. Five of six lines examined showed a dose-dependent proliferative response to chicken T-cell conditioned media. One line, MDCC-CU14, was chosen for further studies. In addition to the tumor cells' dose-dependent responses to semi-purified chicken IL-2, they expressed T-cell activation antigens on the cell surface. Furthermore, the level of surface expression was enhanced on cells provided IL-2. Co-incubation of the tumor cells with monoclonal antibody INN-CH-16 (specific for an antigen on the surface of activated T-cells) and IL-2 resulted in a modulation of lymphokine-induced proliferation. Together, these data suggest that signalling mechanisms in MDV T-cell tumors are intact and that these lines can be used as an assay for chicken T-cell lymphokines. Furthermore, they provide an interesting model for the study of avian and mammalian T-cell transformation. Implications for the study of Marek's disease are also discussed.",
author = "Mark Kaplan and Anju Dhar and Brown, {Thomas R.} and Sundick, {Roy S.}",
year = "1992",
doi = "10.1016/0165-2427(92)90152-G",
language = "English (US)",
volume = "34",
pages = "63--79",
journal = "Veterinary Immunology and Immunopathology",
issn = "0165-2427",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Marek's disease virus-transformed chicken T-cell lines respond to lymphokines

AU - Kaplan, Mark

AU - Dhar, Anju

AU - Brown, Thomas R.

AU - Sundick, Roy S.

PY - 1992

Y1 - 1992

N2 - Current assays for chicken interleukin-2 (IL-2) utilize mitogen-activated lymphocytes. However, very high inter-assay variability and sporadic high background proliferation limit their usefulness. In view of the above, several Marek's disease virus (MDV)-transformed T-cell lines (which grow well in a serum-supplemented medium) were tested for a response to chicken IL-2 when grown in serum-free media. Five of six lines examined showed a dose-dependent proliferative response to chicken T-cell conditioned media. One line, MDCC-CU14, was chosen for further studies. In addition to the tumor cells' dose-dependent responses to semi-purified chicken IL-2, they expressed T-cell activation antigens on the cell surface. Furthermore, the level of surface expression was enhanced on cells provided IL-2. Co-incubation of the tumor cells with monoclonal antibody INN-CH-16 (specific for an antigen on the surface of activated T-cells) and IL-2 resulted in a modulation of lymphokine-induced proliferation. Together, these data suggest that signalling mechanisms in MDV T-cell tumors are intact and that these lines can be used as an assay for chicken T-cell lymphokines. Furthermore, they provide an interesting model for the study of avian and mammalian T-cell transformation. Implications for the study of Marek's disease are also discussed.

AB - Current assays for chicken interleukin-2 (IL-2) utilize mitogen-activated lymphocytes. However, very high inter-assay variability and sporadic high background proliferation limit their usefulness. In view of the above, several Marek's disease virus (MDV)-transformed T-cell lines (which grow well in a serum-supplemented medium) were tested for a response to chicken IL-2 when grown in serum-free media. Five of six lines examined showed a dose-dependent proliferative response to chicken T-cell conditioned media. One line, MDCC-CU14, was chosen for further studies. In addition to the tumor cells' dose-dependent responses to semi-purified chicken IL-2, they expressed T-cell activation antigens on the cell surface. Furthermore, the level of surface expression was enhanced on cells provided IL-2. Co-incubation of the tumor cells with monoclonal antibody INN-CH-16 (specific for an antigen on the surface of activated T-cells) and IL-2 resulted in a modulation of lymphokine-induced proliferation. Together, these data suggest that signalling mechanisms in MDV T-cell tumors are intact and that these lines can be used as an assay for chicken T-cell lymphokines. Furthermore, they provide an interesting model for the study of avian and mammalian T-cell transformation. Implications for the study of Marek's disease are also discussed.

UR - http://www.scopus.com/inward/record.url?scp=0026673388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026673388&partnerID=8YFLogxK

U2 - 10.1016/0165-2427(92)90152-G

DO - 10.1016/0165-2427(92)90152-G

M3 - Article

C2 - 1332253

AN - SCOPUS:0026673388

VL - 34

SP - 63

EP - 79

JO - Veterinary Immunology and Immunopathology

JF - Veterinary Immunology and Immunopathology

SN - 0165-2427

IS - 1-2

ER -